In the last trading session, 6.06 million shares of the ATAI Life Sciences N.V (NASDAQ:ATAI) were traded, and its beta was 0.90. Most recently the company’s share price was $1.61, and it changed around $0.24 or 17.52% from the last close, which brings the market valuation of the company to $317.49M. ATAI currently trades at a discount to its 52-week high of $2.85, offering almost -77.02% off that amount. The share price’s 52-week low was $1.02, which indicates that the current value has risen by an impressive 36.65% since then. We note from ATAI Life Sciences N.V’s average daily trading volume that its 10-day average is 2.68 million shares, with the 3-month average coming to 829.24K.
ATAI Life Sciences N.V stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ATAI as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ATAI Life Sciences N.V (NASDAQ:ATAI) trade information
Instantly ATAI has showed a green trend with a performance of 17.52% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.6510 on recent trading dayincreased the stock’s daily price by 2.48%. The company’s shares are currently up 14.18% year-to-date, but still up 14.18% over the last five days. On the other hand, ATAI Life Sciences N.V (NASDAQ:ATAI) is 34.17% up in the 30-day period. We can see from the shorts that 9.43 million shares have been sold at a short interest cover period of 13.4 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 73.17% from its current value. Analyst projections state that ATAI is forecast to be at a low of $6 and a high of $6.
ATAI Life Sciences N.V (ATAI) estimates and forecasts
ATAI Life Sciences N.V share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -5.85 percent over the past six months and at a -216.00% annual growth rate that is well below the industry average of 13.40%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 44.19%.
ATAI Dividends
ATAI Life Sciences N.V’s next quarterly earnings report is expected to be released in December.
ATAI Life Sciences N.V (NASDAQ:ATAI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.99% of ATAI Life Sciences N.V shares, and 26.84% of them are in the hands of institutional investors. The stock currently has a share float of 29.82%. ATAI Life Sciences N.V stock is held by 106.0 institutions, with WALLEYE CAPITAL LLC being the largest institutional investor. By 2024-06-30, it held 1.7388% of the shares, which is about 2.76 million shares worth $3.67 million.
MORGAN STANLEY, with 1.7111% or 2.72 million shares worth $3.62 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
